139 related articles for article (PubMed ID: 10774145)
21. Amelanotic malignant melanoma of the esophagus: report of a patient with recurrence successfully treated with chemoendocrine therapy.
Suzuki Y; Aoyama N; Minamide J; Takata K; Ogata T
Int J Clin Oncol; 2005 Jun; 10(3):204-7. PubMed ID: 15990972
[TBL] [Abstract][Full Text] [Related]
22. Chemoimmunotherapy for disseminated malignant melanoma with DTIC, ACNU, VCR and OK432. Case presentation of two complete and one partial reponse out of fifteen attempts.
Chiba M; Jimbow K; Kizukuri K; Homma K
J Dermatol; 1982 Feb; 9(1):23-30. PubMed ID: 7047605
[No Abstract] [Full Text] [Related]
23. Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report.
Fukunaga T; Soejima H; Sugamura K; Kojima S; Sugiyama S; Sakamoto T; Yoshimura M; Tanoue T; Kageshita T; Ono T; Ogawa H
J Cardiol; 2006 Apr; 47(4):191-5. PubMed ID: 16637253
[TBL] [Abstract][Full Text] [Related]
24. Malignant melanoma of the breast: N-isopropyl-p-(123) I-iodoamphetamine single photon emission computed tomography ((123) I-IMP SPECT) is useful for the detection of metastasis.
Ito Y; Doi H; Tsuji H; Ishida-Yamamto A; Iizuka H
J Dermatol; 2010 Sep; 37(9):849-51. PubMed ID: 20883378
[No Abstract] [Full Text] [Related]
25. [Metastatic malignant melanoma of the urinary bladder: a case report].
Nohara T; Sakai A; Fuse H; Imamura Y
Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):707-11. PubMed ID: 19999137
[TBL] [Abstract][Full Text] [Related]
26. High-dose, double alkylating agent chemotherapy with DTIC, melphalan, or ifosfamide and marrow rescue for metastatic malignant melanoma.
Thatcher D; Lind M; Morgenstern G; Carr T; Chadwick G; Jones R; Craig P
Cancer; 1989 Apr; 63(7):1296-302. PubMed ID: 2646005
[TBL] [Abstract][Full Text] [Related]
27. [Late results of the conservative treatment of melanoma of the skin].
Kogoniia LM; Manziuk LV; Marenich AF; Osmanov DSh; Roshchin EM
Sov Med; 1986; (11):101-2. PubMed ID: 3563661
[No Abstract] [Full Text] [Related]
28. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy (part II)].
Ishihara K; Hayasaka K; Ikeda S; Terakado T; Kukita A; Seki Y; Jimbow K; Suzuki M
Gan To Kagaku Ryoho; 1984 Mar; 11(3):467-73. PubMed ID: 6703721
[TBL] [Abstract][Full Text] [Related]
29. [New combination chemotherapy for malignant melanoma--PAV(peplomycin, ACNU, VCR) therapy].
Ikeda S; Tajima K; Miyasato H; Terakado T; Suzuki T; Miura T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2198-204. PubMed ID: 6194756
[TBL] [Abstract][Full Text] [Related]
30. Paralytic ileus associated with a combination of dacarbazine-nimustine hydrochloride-vincristine chemotherapy.
Takata Y; Hayashi S; Ohno T; Dekio S
J Dermatol; 1997 Oct; 24(10):682-3. PubMed ID: 9375471
[No Abstract] [Full Text] [Related]
31. Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-alpha.
Vuoristo M; Gröhn P; Kumpulainen E; Korpela M
Eur J Cancer; 1994; 30A(3):420. PubMed ID: 7515632
[No Abstract] [Full Text] [Related]
32. [An autopsy case of neurocutaneous melanosis associated with intracerebral malignant melanoma].
Sawamura Y; Abe H; Murai H; Tashiro K; Doi S
No To Shinkei; 1987 Aug; 39(8):789-95. PubMed ID: 3322333
[TBL] [Abstract][Full Text] [Related]
33. Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study.
Robert C; Dummer R; Gutzmer R; Lorigan P; Kim KB; Nyakas M; Arance A; Liszkay G; Schadendorf D; Cantarini M; Spencer S; Middleton MR
Lancet Oncol; 2013 Jul; 14(8):733-40. PubMed ID: 23735514
[TBL] [Abstract][Full Text] [Related]
34. Dacarbazine in combination with bevacizumab for the treatment of unresectable/metastatic melanoma: a phase II study.
Ferrucci PF; Minchella I; Mosconi M; Gandini S; Verrecchia F; Cocorocchio E; Passoni C; Pari C; Testori A; Coco P; Munzone E
Melanoma Res; 2015 Jun; 25(3):239-45. PubMed ID: 25746039
[TBL] [Abstract][Full Text] [Related]
35. A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma.
Hersey P; Sosman J; O'Day S; Richards J; Bedikian A; Gonzalez R; Sharfman W; Weber R; Logan T; Buzoianu M; Hammershaimb L; Kirkwood JM;
Cancer; 2010 Mar; 116(6):1526-34. PubMed ID: 20108344
[TBL] [Abstract][Full Text] [Related]
36. [Malignant melanoma of the alimentary tract].
Nakamura T; Ide H
Gan To Kagaku Ryoho; 2003 May; 30(5):619-25. PubMed ID: 12795092
[TBL] [Abstract][Full Text] [Related]
37. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy].
Jimbow K; Takahashi H; Ishihara K; Hayasaka K; Kukita A; Seki Y; Ikeda S; Terakado T
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1942-9. PubMed ID: 7184382
[TBL] [Abstract][Full Text] [Related]
38. Malignant melanoma treated with natural interferons alfa and beta and DAV.
Nagatani T; Ichiyama S; Miyakawa K; Uchiyama M
Eur J Cancer; 1992; 28A(10):1774. PubMed ID: 1389506
[No Abstract] [Full Text] [Related]
39. Biochemotherapy for advanced melanoma: maybe it is real.
Khayat D; Bernard-Marty C; Meric JB; Rixe O
J Clin Oncol; 2002 May; 20(10):2411-4. PubMed ID: 12011117
[No Abstract] [Full Text] [Related]
40. Similar efficacy for phase I trials in comparison with DTIC for advanced malignant melanoma: an analysis of melanoma outcomes in CTEP-sponsored phase I trials 1995-2011.
Luke JJ; Rubinstein LV; Smith GL; Ivy SP; Harris PJ
Melanoma Res; 2013 Apr; 23(2):152-8. PubMed ID: 23411478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]